Copper Peptide Science — GHK-Cu 2%
Peptides,
without the needle.
Clinically studied GHK-Cu at an efficacious 2% — regenerative peptide results delivered through the skin, not a syringe.
Clinical formulations,
with integrity.
Every RHIVA formula is built around a single efficacious active at a meaningful concentration. No padding, no filler, no compromise.
Find Your Formula.
Answer two questions. We'll match you to the right RHIVA formulation.
The molecule that
rebuilds skin.
GHK-Cu — Glycyl-L-Histidyl-L-Lysine copper(II) — is a naturally occurring tripeptide first isolated from human plasma in 1973. Present in the skin at birth, its concentration declines by over 60% between the ages of 20 and 60. With it goes the skin's capacity to repair itself.
At 2%, RHIVA reaches the threshold shown in peer-reviewed studies to activate collagen synthesis, stimulate fibroblast production, and initiate the skin's own tissue repair cascade. Not surface-level hydration — structural regeneration.
What to expect,
week by week.
12-week observational study. 42 participants aged 32-58 applying RHIVA GHK-Cu Serum twice daily. No concurrent actives. Results self-reported and dermatologist-corroborated.
Real results,
real people.
Peptide science,
in your inbox.
Early access to new formulas, clinical update letters, and founding customer pricing. No noise — just signal.
No spam. Unsubscribe at any time. rhivaskin.com


